EdenTree Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

EdenTree Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.44M	Hold	25,000	–	–	0.44%	47
2026 Q1	$1.52M	Hold	25,000	–	–	0.46%	45
2025 Q4	$1.35M	Hold	25,000	–	–	0.41%	45
2025 Q3	$1.13M	Hold	25,000	–	–	0.27%	50
2025 Q2	$1.16M	Hold	25,000	–	–	0.32%	49
2025 Q1	$1.53M	Hold	25,000	–	–	0.51%	42
2024 Q4	$1.41M	Hold	25,000	–	–	0.41%	51
2024 Q3	$1.29M	Hold	25,000	–	–	0.37%	51
2024 Q2	$1.04M	Hold	25,000	–	–	0.33%	55
2024 Q1	$1.36M	Sell	25,000 -67,450	-73%	-$3.44M	0.43%	42
2023 Q4	$4.74M	Buy	92,450 +3,000	+3%	+$157K	1.47%	23
2023 Q3	$5.19M	Buy	89,450 +12,000	+15%	+$735K	2.04%	20
2023 Q2	$4.95M	Buy	+77,450	New	+$5.19M	1.7%	22

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

EdenTree Asset Management's BMY Position: Q2 2026 in Review

EdenTree Asset Management held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 25,000 shares worth $1.44M. The position accounts for 0.44% of the portfolio, ranked #47.

EdenTree Asset Management first reported a position in BMY in Q2 2023 and has held it in 13 quarters since. The position peaked at $5.19M in Q3 2023. 2,526 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

EdenTree Asset Management held 25,000 shares of Bristol-Myers Squibb worth $1.44M as of Q2 2026.
EdenTree Asset Management left its Bristol-Myers Squibb share count unchanged in Q2 2026.
Bristol-Myers Squibb made up 0.44% of EdenTree Asset Management's portfolio in Q2 2026, its #47 holding.
EdenTree Asset Management first reported a position in Bristol-Myers Squibb in Q2 2023 and has held it in 13 quarters since.
EdenTree Asset Management's Bristol-Myers Squibb position peaked at $5.19M in Q3 2023.
2,526 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on EdenTree Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.